Cnbx Pharmaceuticals

(OTC) CNBX

Current Price$0.00

Market Cap$245.20K

Since IPO (2011)-100%

5 Year-100%

1 Year-78%

1 Month+0%

Cnbx Pharmaceuticals Financials at a Glance

Market Cap

$245.20K

Revenue (TTM)

$0.00

Net Income (TTM)

-$367.65K

EPS (TTM)

-$0.00

P/E Ratio

-0.11

Dividend

$0.00

Beta (Volatility)

0.67 (Low)

Dividend

$0.00

Beta (Volatility)

0.67 (Low)

Price

$0.00

Volume

17,499,838

Open

$0.00

Price

$0.00

Volume

17,499,838

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

Apr 13, 2026

Dividend

$0.00

Beta (Volatility)

0.67 (Low)

Price

$0.00

Volume

17,499,838

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

Apr 13, 2026

CNBX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cnbx Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Eyal Barad, MBA

Website

www.cnbxpharma.com

Headquarters

Bethesda, MD 20814, US

CNBX Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

12%

Return on Assets

-25%

Earnings Yield

-9.09%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$245.20K

Shares Outstanding

1.23B

Volume

17.50M

Avg. Volume

35.14M

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$271.69K

EBITDA

-$273.79K

Operating Cash Flow

-$171.31K

Capital Expenditure

$0.00

Free Cash Flow

-$171.31K

Cash & ST Invst.

$15.11K

Total Debt

$1.20M

Cnbx Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$245.20K

N/A

Market Cap/Employee

$245.20K

N/A

Employees

N/A

Net Income

-$44.10K

+36.8%

EBITDA

-$72.96K

-12.7%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

$12.15K

-73.4%

Total Debt

$75.00K

-94.6%

Accounts Receivable

$2.75K

-44.9%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$75.00K

-94.6%

Return on Assets

-24.68%

N/A

Return on Invested Capital

12.12%

N/A

Free Cash Flow

-$30.55K

+40.9%

Operating Cash Flow

-$30.55K

+40.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

TNPHTian'an Pharmaceutical Co., Ltd.

TNPHTian'an Pharmaceutical Co., Ltd.$0.01+0.00%

AFFYAffymax, Inc.

AFFYAffymax, Inc.$0.00+10.00%

ENDVEndonovo Therapeutics, Inc.

ENDVEndonovo Therapeutics, Inc.$0.00+0.00%

MCRTMicroart Inc.

MCRTMicroart Inc.$0.00+0.00%

ITMCItoco Inc.

ITMCItoco Inc.$0.00+0.00%

ACURAcura Pharmaceuticals, Inc.

ACURAcura Pharmaceuticals, Inc.$0.00+0.00%

GNLKQGeneLink, Inc.

GNLKQGeneLink, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$160.95+0.19%

INTCIntel

INTCIntel$124.57+0.07%

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

ONDSOndas

ONDSOndas$9.33-0.05%

Questions About CNBX

What is the current price of Cnbx Pharmaceuticals?

Cnbx Pharmaceuticals is trading at $0.00 per share.

What is the 52-week range for Cnbx Pharmaceuticals?

Over the past 52 weeks, Cnbx Pharmaceuticals has traded between $0.00 and $0.01.

How much debt does Cnbx Pharmaceuticals have?

As of the most recent reporting period, Cnbx Pharmaceuticals reported total debt of $1.17M.

How much cash does Cnbx Pharmaceuticals have on hand?

Cnbx Pharmaceuticals reported $12.15K in cash and cash equivalents in its most recent financial results.

What is Cnbx Pharmaceuticals’s dividend yield?

Cnbx Pharmaceuticals does not currently have a dividend yield.

Cnbx Pharmaceuticals

Cnbx Pharmaceuticals Financials at a Glance

CNBX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cnbx Pharmaceuticals

CNBX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cnbx Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CNBX

What is the current price of Cnbx Pharmaceuticals?

What is the 52-week range for Cnbx Pharmaceuticals?

How much debt does Cnbx Pharmaceuticals have?

How much cash does Cnbx Pharmaceuticals have on hand?

What is Cnbx Pharmaceuticals’s dividend yield?

Premium Investing Services